10-Q Filing

ARROWHEAD PHARMACEUTICALS, INC. CIK: 879407 Q2 2020

Filing Information

Form Type	10-Q
Accession Number	`0001564590-20-022860`
Period End Date	20200331
Filing Date	20200507
Fiscal Year	2020
Fiscal Period	Q2
XBRL Instance	arwr-10q_20200331_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 72 Income Statement 60 Cash Flow Statement 52 Stockholders Equity 32

Balance Sheet 72 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	145.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	145.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	101.75M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	95.51M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$221.80M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$256.65M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	95.51M	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$1.27M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$661.36K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	101.75M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$3.32M	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$3.06M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$2.54M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$2.56M	USD	Point-in-time
Short term investments	`HeldToMaturitySecuritiesCurrent`	$50.96M	USD	Point-in-time
Short term investments	`HeldToMaturitySecuritiesCurrent`	$36.90M	USD	Point-in-time
TOTAL CURRENT ASSETS	`AssetsCurrent`	$265.25M	USD	Point-in-time
TOTAL CURRENT ASSETS	`AssetsCurrent`	$314.47M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$23.21M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$29.36M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$16.21M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$17.06M	USD	Point-in-time
Long term investments	`HeldToMaturitySecuritiesNoncurrent`	$44.18M	USD	Point-in-time
Long term investments	`HeldToMaturitySecuritiesNoncurrent`	$190.62M	USD	Point-in-time
Right-of-use assets	`OperatingLeaseRightOfUseAsset`	$10.26M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$144.15K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$144.15K	USD	Point-in-time
TOTAL ASSETS	`Assets`	$561.08M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$349.85M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$13.42M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$7.65M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$6.50M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$4.42M	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$4.96M	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$1.62M	USD	Point-in-time
Lease liabilities	`OperatingLeaseLiabilityCurrent`	$688.45K	USD	Point-in-time
Deferred rent	`DeferredRentCreditCurrent`	$173.95K	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$77.77M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$33.17M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$17.26K	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$16.56K	USD	Point-in-time
TOTAL CURRENT LIABILITIES	`LiabilitiesCurrent`	$53.33M	USD	Point-in-time
TOTAL CURRENT LIABILITIES	`LiabilitiesCurrent`	$97.07M	USD	Point-in-time
Lease liabilities, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$14.18M	USD	Point-in-time
Deferred rent, net of current portion	`DeferredRentCreditNoncurrent`	$3.70M	USD	Point-in-time
Deferred revenue, net of current portion	`ContractWithCustomerLiabilityNoncurrent`	$5.04M	USD	Point-in-time
TOTAL LONG-TERM LIABILITIES	`LiabilitiesNoncurrent`	$14.18M	USD	Point-in-time
TOTAL LONG-TERM LIABILITIES	`LiabilitiesNoncurrent`	$8.74M	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.001 par value; 145,000,000 shares authorized; 101,748,107 and 95,506,271 shares issued and outstanding as of March 31, 2020 and September 30, 2019, respectively	`CommonStockValue`	$194.12K	USD	Point-in-time
Common stock, $0.001 par value; 145,000,000 shares authorized; 101,748,107 and 95,506,271 shares issued and outstanding as of March 31, 2020 and September 30, 2019, respectively	`CommonStockValue`	$187.88K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$936.35M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$664.09M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-391.62K	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-629.11K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-419.29M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-441.80M	USD	Point-in-time
Total Arrowhead Pharmaceuticals, Inc. stockholders' equity	`StockholdersEquity`	$494.12M	USD	Point-in-time
Total Arrowhead Pharmaceuticals, Inc. stockholders' equity	`StockholdersEquity`	$244.59M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-555.19K	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-555.19K	USD	Point-in-time
TOTAL STOCKHOLDERS EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$171.50M	USD	Point-in-time
TOTAL STOCKHOLDERS EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$499.53M	USD	Point-in-time
TOTAL STOCKHOLDERS EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$493.56M	USD	Point-in-time
TOTAL STOCKHOLDERS EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$200.64M	USD	Point-in-time
TOTAL STOCKHOLDERS EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$95.24M	USD	Point-in-time
TOTAL STOCKHOLDERS EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$244.04M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY	`LiabilitiesAndStockholdersEquity`	$349.85M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY	`LiabilitiesAndStockholdersEquity`	$561.08M	USD	Point-in-time

Income Statement 60 line items

Line Item	Tag	Value	Unit	Period
REVENUE	`RevenueFromContractWithCustomerExcludingAssessedTax`	$52.98M	USD	2 Qtrs
REVENUE	`RevenueFromContractWithCustomerExcludingAssessedTax`	$48.15M	USD	1 Quarter
REVENUE	`RevenueFromContractWithCustomerExcludingAssessedTax`	$23.53M	USD	1 Quarter
REVENUE	`RevenueFromContractWithCustomerExcludingAssessedTax`	$82.81M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$38.37M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$52.82M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$20.80M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$29.44M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$11.48M	USD	2 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$5.34M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$27.26M	USD	2 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$16.33M	USD	1 Quarter
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$80.08M	USD	2 Qtrs
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$45.77M	USD	1 Quarter
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$26.14M	USD	1 Quarter
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$49.85M	USD	2 Qtrs
OPERATING INCOME (LOSS)	`OperatingIncomeLoss`	$22.01M	USD	1 Quarter
OPERATING INCOME (LOSS)	`OperatingIncomeLoss`	$32.96M	USD	2 Qtrs
OPERATING INCOME (LOSS)	`OperatingIncomeLoss`	$-22.24M	USD	1 Quarter
OPERATING INCOME (LOSS)	`OperatingIncomeLoss`	$-27.09M	USD	2 Qtrs
Interest income (expense), net	`InterestIncomeExpenseNonoperatingNet`	$1.89M	USD	1 Quarter
Interest income (expense), net	`InterestIncomeExpenseNonoperatingNet`	$2.98M	USD	2 Qtrs
Interest income (expense), net	`InterestIncomeExpenseNonoperatingNet`	$4.58M	USD	2 Qtrs
Interest income (expense), net	`InterestIncomeExpenseNonoperatingNet`	$2.40M	USD	1 Quarter
TOTAL OTHER INCOME (EXPENSE)	`NonoperatingIncomeExpense`	$2.40M	USD	1 Quarter
TOTAL OTHER INCOME (EXPENSE)	`NonoperatingIncomeExpense`	$2.98M	USD	2 Qtrs
TOTAL OTHER INCOME (EXPENSE)	`NonoperatingIncomeExpense`	$1.89M	USD	1 Quarter
TOTAL OTHER INCOME (EXPENSE)	`NonoperatingIncomeExpense`	$4.58M	USD	2 Qtrs
INCOME (LOSS) BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-19.84M	USD	1 Quarter
INCOME (LOSS) BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$35.93M	USD	2 Qtrs
INCOME (LOSS) BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-22.51M	USD	2 Qtrs
INCOME (LOSS) BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$23.90M	USD	1 Quarter
NET INCOME (LOSS)	`NetIncomeLoss`	$23.90M	USD	1 Quarter
NET INCOME (LOSS)	`NetIncomeLoss`	$-22.51M	USD	2 Qtrs
NET INCOME (LOSS)	`NetIncomeLoss`	$35.93M	USD	2 Qtrs
NET INCOME (LOSS)	`NetIncomeLoss`	$-19.84M	USD	1 Quarter
NET INCOME (LOSS) PER SHARE - BASIC	`EarningsPerShareBasic`	$0.39	USD	2 Qtrs
NET INCOME (LOSS) PER SHARE - BASIC	`EarningsPerShareBasic`	$-0.20	USD	1 Quarter
NET INCOME (LOSS) PER SHARE - BASIC	`EarningsPerShareBasic`	$0.25	USD	1 Quarter
NET INCOME (LOSS) PER SHARE - BASIC	`EarningsPerShareBasic`	$-0.23	USD	2 Qtrs
NET INCOME (LOSS) PER SHARE - DILUTED	`EarningsPerShareDiluted`	$0.24	USD	1 Quarter
NET INCOME (LOSS) PER SHARE - DILUTED	`EarningsPerShareDiluted`	$-0.20	USD	1 Quarter
NET INCOME (LOSS) PER SHARE - DILUTED	`EarningsPerShareDiluted`	$-0.23	USD	2 Qtrs
NET INCOME (LOSS) PER SHARE - DILUTED	`EarningsPerShareDiluted`	$0.37	USD	2 Qtrs
Weighted average shares outstanding - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	101.65M	shares	1 Quarter
Weighted average shares outstanding - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	94.16M	shares	1 Quarter
Weighted average shares outstanding - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	99.36M	shares	2 Qtrs
Weighted average shares outstanding - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	92.62M	shares	2 Qtrs
Weighted average shares outstanding - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	99.36M	shares	2 Qtrs
Weighted average shares outstanding - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	97.21M	shares	2 Qtrs
Weighted average shares outstanding - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	98.08M	shares	1 Quarter
Weighted average shares outstanding - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	101.65M	shares	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-28.16K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-50.34K	USD	2 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-237.49K	USD	2 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-433.56K	USD	1 Quarter
COMPREHENSIVE INCOME (LOSS)	`ComprehensiveIncomeNetOfTax`	$23.87M	USD	1 Quarter
COMPREHENSIVE INCOME (LOSS)	`ComprehensiveIncomeNetOfTax`	$35.88M	USD	2 Qtrs
COMPREHENSIVE INCOME (LOSS)	`ComprehensiveIncomeNetOfTax`	$-20.27M	USD	1 Quarter
COMPREHENSIVE INCOME (LOSS)	`ComprehensiveIncomeNetOfTax`	$-22.75M	USD	2 Qtrs

Cash Flow Statement 52 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`ProfitLoss`	$-22.51M	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$35.93M	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$23.90M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-19.84M	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$17.46M	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$5.32M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$2.63M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$2.35M	USD	2 Qtrs
Amortization/(accretion) of note premiums	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$-419.21K	USD	2 Qtrs
Amortization/(accretion) of note premiums	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$-330.23K	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$13.09M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$604.41K	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$1.44M	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-46.52K	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$120.62M	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-49.63M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$1.26M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$5.77M	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-5.42M	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-2.34M	USD	2 Qtrs
Other	`IncreaseDecreaseInOtherOperatingLiabilities`	$-240.74K	USD	2 Qtrs
Other	`IncreaseDecreaseInOtherOperatingLiabilities`	$725.48K	USD	2 Qtrs
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES	`NetCashProvidedByUsedInOperatingActivities`	$148.70M	USD	2 Qtrs
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES	`NetCashProvidedByUsedInOperatingActivities`	$-51.11M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$7.93M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$946.79K	USD	2 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$180.52M	USD	2 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$90.27M	USD	2 Qtrs
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$12.24M	USD	2 Qtrs
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$19.60M	USD	2 Qtrs
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES	`NetCashProvidedByUsedInInvestingActivities`	$-168.85M	USD	2 Qtrs
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES	`NetCashProvidedByUsedInInvestingActivities`	$-78.97M	USD	2 Qtrs
Principal payments on notes payable	`RepaymentsOfNotesPayable`	$2.42M	USD	2 Qtrs
Proceeds from the exercises of stock options	`ProceedsFromStockOptionsExercised`	$4.33M	USD	2 Qtrs
Proceeds from the exercises of stock options	`ProceedsFromStockOptionsExercised`	$3.67M	USD	2 Qtrs
Proceeds from the issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$250.48M	USD	2 Qtrs
Proceeds from the issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$250.50M	USD	Point-in-time
Proceeds from the issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$60.52M	USD	2 Qtrs
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES	`NetCashProvidedByUsedInFinancingActivities`	$61.78M	USD	2 Qtrs
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES	`NetCashProvidedByUsedInFinancingActivities`	$254.81M	USD	2 Qtrs
NET INCREASE (DECREASE) IN CASH	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$34.85M	USD	2 Qtrs
NET INCREASE (DECREASE) IN CASH	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$131.51M	USD	2 Qtrs
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$221.80M	USD	Point-in-time
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$256.65M	USD	Point-in-time
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$30.13M	USD	Point-in-time
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$161.64M	USD	Point-in-time
CASH AND CASH EQUIVALENTS AT END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$221.80M	USD	Point-in-time
CASH AND CASH EQUIVALENTS AT END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$256.65M	USD	Point-in-time
CASH AND CASH EQUIVALENTS AT END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$30.13M	USD	Point-in-time
CASH AND CASH EQUIVALENTS AT END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$161.64M	USD	Point-in-time
Interest paid	`InterestPaidNet`	$27.44K	USD	2 Qtrs
Income Taxes Paid	`IncomeTaxesPaid`	$2.40K	USD	2 Qtrs

Stockholders Equity 32 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$171.50M	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$499.53M	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$493.56M	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$200.64M	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$95.24M	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$244.04M	USD	Point-in-time
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$5.32M	USD	2 Qtrs
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$2.60M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$17.46M	USD	2 Qtrs
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$12.97M	USD	1 Quarter
Exercise of stock options, Amount	`StockIssuedDuringPeriodValueStockOptionsExercised`	$4.33M	USD	2 Qtrs
Exercise of stock options, Amount	`StockIssuedDuringPeriodValueStockOptionsExercised`	$3.67M	USD	2 Qtrs
Exercise of stock options, Amount	`StockIssuedDuringPeriodValueStockOptionsExercised`	$1.33M	USD	1 Quarter
Exercise of stock options, Amount	`StockIssuedDuringPeriodValueStockOptionsExercised`	$2.67M	USD	1 Quarter
Exercise of stock options, Shares	`StockIssuedDuringPeriodSharesStockOptionsExercised`	686,432.00	shares	2 Qtrs
Common stock - issued for cash, Amount	`StockIssuedDuringPeriodValueNewIssues`	$250.48M	USD	2 Qtrs
Common stock - issued for cash, Amount	`StockIssuedDuringPeriodValueNewIssues`	$60.52M	USD	2 Qtrs
Common stock - issued for cash, Amount	`StockIssuedDuringPeriodValueNewIssues`	$2.23K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-28.16K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-50.34K	USD	2 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-237.49K	USD	2 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-433.56K	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-22.51M	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$35.93M	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$23.90M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-19.84M	USD	1 Quarter
Ending Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$171.50M	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$499.53M	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$493.56M	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$200.64M	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$95.24M	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$244.04M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.